| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
30,390 |
23,947 |
$2.06M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15,956 |
10,710 |
$894K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,421 |
6,202 |
$682K |
| 96367 |
|
10,669 |
6,775 |
$456K |
| 96417 |
|
4,937 |
2,827 |
$356K |
| 36000 |
|
7,382 |
5,090 |
$200K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,274 |
15,116 |
$127K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
548 |
359 |
$118K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
853 |
853 |
$118K |
| 99070 |
|
11,458 |
7,706 |
$109K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,054 |
1,685 |
$55K |
| 99205 |
Prolong outpt/office vis |
419 |
419 |
$49K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,398 |
2,582 |
$46K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
210 |
148 |
$44K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
980 |
316 |
$40K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
15 |
12 |
$28K |
| 96415 |
|
969 |
708 |
$25K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
8,732 |
4,908 |
$23K |
| J0897 |
Injection, denosumab, 1 mg |
14 |
13 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
967 |
671 |
$16K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,362 |
4,908 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
281 |
144 |
$12K |
| J1750 |
Injection, iron dextran, 50 mg |
184 |
161 |
$12K |
| 99223 |
Prolong inpt eval add15 m |
101 |
100 |
$9K |
| 99215 |
Prolong outpt/office vis |
64 |
62 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,267 |
3,760 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,274 |
867 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
26 |
26 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60 |
57 |
$2K |
| 96523 |
|
89 |
61 |
$2K |
| J9190 |
Injection, fluorouracil, 500 mg |
469 |
213 |
$2K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
263 |
114 |
$869.80 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
49 |
36 |
$856.06 |
| J9267 |
Injection, paclitaxel, 1 mg |
59 |
38 |
$584.02 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
46 |
25 |
$508.13 |
| J9045 |
Injection, carboplatin, 50 mg |
56 |
28 |
$358.98 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,402 |
893 |
$293.70 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
20 |
12 |
$218.29 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
15 |
12 |
$192.48 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
27 |
12 |
$164.27 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
136 |
115 |
$146.43 |
| 36415 |
Collection of venous blood by venipuncture |
188 |
140 |
$86.05 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
32 |
20 |
$39.60 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
26 |
12 |
$29.02 |
| J3480 |
Injection, potassium chloride, per 2 meq |
26 |
12 |
$14.70 |